Open AccessChanges in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection
Author(s) -
Jinghua Chen,
Qichen Chen,
Jinjie Yao,
Yujuan Jiang,
Jianguo Zhou,
Hong Zhao,
Jianqiang Cai
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-584
Subject(s) - medicine , lactate dehydrogenase , pathological , confidence interval , colorectal cancer , odds ratio , proportional hazards model , logistic regression , gastroenterology , multivariate analysis , chemotherapy , univariate analysis , oncology , cancer , chemistry , biochemistry , enzyme
This study sought to evaluate the effects of pre-neoadjuvant chemotherapy lactate dehydrogenase (pre-NAC LDH) levels, preoperative LDH levels, and changes in LDH levels on the pathological response and outcomes of colorectal liver metastases (CRLM) patients treated with liver resection after NAC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom